These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 35091453)

  • 1. CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of T
    Benoit-Lizon I; Jacquin E; Rivera Vargas T; Richard C; Roussey A; Dal Zuffo L; Martin T; Melis A; Vinokurova D; Shahoei SH; Baeza Garcia A; Pignol C; Giorgiutti S; Carapito R; Boidot R; Végran F; Flavell RA; Ryffel B; Nelson ER; Soulas-Sprauel P; Lawrence T; Apetoh L
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35091453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal regulation of STING and TCR signaling by mTORC1 for T-cell activation and function.
    Imanishi T; Unno M; Kobayashi W; Yoneda N; Matsuda S; Ikeda K; Hoshii T; Hirao A; Miyake K; Barber GN; Arita M; Ishii KJ; Akira S; Saito T
    Life Sci Alliance; 2019 Feb; 2(1):. PubMed ID: 30683688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
    Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer.
    Ni H; Zhang H; Li L; Huang H; Guo H; Zhang L; Li C; Xu JX; Nie CP; Li K; Zhang X; Xia X; Li J
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36126994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STING trafficking activates MAPK-CREB signaling to trigger regulatory T cell differentiation.
    Lin W; Szabo C; Liu T; Tao H; Wu X; Wu J
    Proc Natl Acad Sci U S A; 2024 Jul; 121(29):e2320709121. PubMed ID: 38985760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response.
    Li T; Cheng H; Yuan H; Xu Q; Shu C; Zhang Y; Xu P; Tan J; Rui Y; Li P; Tan X
    Sci Rep; 2016 Jan; 6():19049. PubMed ID: 26754564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll like Receptor 2 engagement on CD4
    Karim AF; Reba SM; Li Q; Boom WH; Rojas RE
    Eur J Immunol; 2017 Sep; 47(9):1513-1524. PubMed ID: 28665005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer.
    Cheng N; Watkins-Schulz R; Junkins RD; David CN; Johnson BM; Montgomery SA; Peine KJ; Darr DB; Yuan H; McKinnon KP; Liu Q; Miao L; Huang L; Bachelder EM; Ainslie KM; Ting JP
    JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cGAMP via the STING pathway in modulating germinal center responses and CD4 T cell differentiation.
    Yoon M; Choi Y; Wi T; Choi YS; Choi J
    Front Immunol; 2024; 15():1340001. PubMed ID: 38680492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion.
    Ye ZJ; Zhou Q; Yin W; Yuan ML; Yang WB; Xiong XZ; Zhang JC; Shi HZ
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1168-79. PubMed ID: 23065014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression.
    Tsukamoto H; Nishikata R; Senju S; Nishimura Y
    Cancer Immunol Res; 2013 Jul; 1(1):64-76. PubMed ID: 24777249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.
    Temizoz B; Kuroda E; Ohata K; Jounai N; Ozasa K; Kobiyama K; Aoshi T; Ishii KJ
    Eur J Immunol; 2015 Apr; 45(4):1159-69. PubMed ID: 25529558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment.
    Nagata M; Kosaka A; Yajima Y; Yasuda S; Ohara M; Ohara K; Harabuchi S; Hayashi R; Funakoshi H; Ueda J; Kumai T; Nagato T; Oikawa K; Harabuchi Y; Esteban C; Ohkuri T; Kobayashi H
    Cancer Immunol Immunother; 2021 Aug; 70(8):2301-2312. PubMed ID: 33507344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling.
    Brown MC; Mosaheb MM; Mohme M; McKay ZP; Holl EK; Kastan JP; Yang Y; Beasley GM; Hwang ES; Ashley DM; Bigner DD; Nair SK; Gromeier M
    Nat Commun; 2021 Mar; 12(1):1858. PubMed ID: 33767151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential role of IκB
    Frentzel S; Katsoulis-Dimitriou K; Jeron A; Schmitz I; Bruder D
    Eur J Immunol; 2019 Sep; 49(9):1391-1398. PubMed ID: 31049948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Differentiation of Effector CD4
    Read KA; Powell MD; Sreekumar BK; Oestreich KJ
    Methods Mol Biol; 2019; 1960():75-84. PubMed ID: 30798522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amino acid sensor general control nonderepressible 2 (GCN2) controls T
    Wang P; Xu Y; Zhang J; Shi L; Lei T; Hou Y; Lu Z; Zhao Y
    J Allergy Clin Immunol; 2019 Oct; 144(4):1091-1105. PubMed ID: 31121187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th9 Cells Represent a Unique Subset of CD4
    Lu Y; Wang Q; Xue G; Bi E; Ma X; Wang A; Qian J; Dong C; Yi Q
    Cancer Cell; 2018 Jun; 33(6):1048-1060.e7. PubMed ID: 29894691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone Deacetylase SIRT1 Negatively Regulates the Differentiation of Interleukin-9-Producing CD4(+) T Cells.
    Wang Y; Bi Y; Chen X; Li C; Li Y; Zhang Z; Wang J; Lu Y; Yu Q; Su H; Yang H; Liu G
    Immunity; 2016 Jun; 44(6):1337-49. PubMed ID: 27317260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells.
    Nakamura T; Kamogawa Y; Bottomly K; Flavell RA
    J Immunol; 1997 Feb; 158(3):1085-94. PubMed ID: 9013946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.